Você procurou por: antimuscarinic (Inglês - Esloveno)

antimuscarinic
muskarinski antagonist

antimuscarinic activity
antimuskarinsko delovanje

patients with prior oab antimuscarinic therapy
bolniki s predhodnim antimuskarinskim zdravljenjem pasm

antimuscarinic activity resides predominantly in the r-isomer.
antimuskarinsko delovanje je predvsem prisotno v r-izomeru.

dose dependent antimuscarinic adverse reactions are likely to occur.
lahko se pojavijo od odmerka odvisni antimuskarinski neželeni učinki.

patients with prior oab antimuscarinic therapy who discontinued due to insufficient effect
bolniki s predhodnim antimuskarinskim zdravljenjem pasm, ki so to zdravljenje končali zaradi nezadostne učinkovitosti

none of these metabolites contribute significantly to the antimuscarinic activity of fesoterodine.
nobeden od teh presnovkov ne prispeva pomembno k antimuskarinskemu učinku fesoterodina.

glycopyrronium is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine.
glikopironij je kvaterno amonijevo antimuskarinsko zdravilo s perifernimi učinki, ki so podobni učinkom atropina.

betmiga should also be administered with caution to patients taking antimuscarinic medications for the treatment of oab.
zdravilo betmiga je potrebno uporabljati previdno tudi pri bolnikih, ki jemljejo antimuskarinska zdravila za zdravljenje pasm.

toviaz is a so called antimuscarinic medicinal product which reduces the activity of an overactive bladder and treats the symptoms.
zdravilo toviaz sodi v skupino zdravil, imenovanih antimuskarinska zdravila, in zmanjšuje aktivnost čezmerno aktivnega sečnega mehurja ter zdravi njegove simptome.

as with other antimuscarinic agents, emselex may produce effects such as dizziness, blurred vision, insomnia and somnolence.
tako kot druga antimuskarinska zdravila tudi zdravilo emselex lahko povzroča učinke, kot so vrtoglavica, zamegljen vid, nespečnost in zaspanost.

the chmp also noted that there were no major safety concerns with incruse, with side effects being manageable and similar to other antimuscarinic bronchodilator medicines.
ugotovil je tudi, da ni večjih pomislekov glede varnosti zdravila incluse, saj so njegovi neželeni učinki obvladljivi in podobni kot pri drugih antimuskarinskih bronhodilatatorjih.

due to the pharmacological properties of fesoterodine, treatment may cause mild to moderate antimuscarinic effects like dry mouth, dry eye, dyspepsia and constipation.
zaradi farmakoloških lastnosti fesoterodina lahko zdravljenje povzroči blage do zmerne antimuskarinske učinke, kot so suha usta, suhe oči, dispepsija in zaprtje.

the study population consisted of approximately 48% antimuscarinic treatment naïve patients as well as approximately 52% patients previously treated with antimuscarinic medication.
Študijska populacija je obsegala pribliţno 48 % oseb, ki predhodno niso prejemale antimuskarinskih zdravil, in pribliţno 52 % oseb, predhodno ţe zdravljenih z antimuskarinskimi zdravili.

consistent with its antimuscarinic activity, umeclidinium/vilanterol should be used with caution in patients with urinary retention or with narrow-angle glaucoma.
zaradi antimuskarinskega delovanja je treba kombinacijo umeklidinij/vilanterol pri bolnikih z retenco urina ali glavkomom z ozkim zakotjem uporabljati previdno.

as with any other antimuscarinic agents, concomitant use of medicinal products that possess antimuscarinic properties, such as oxybutynin, tolterodine and flavoxate, may result in more pronounced therapeutic and side effects.
tako kot pri drugih antimuskarinskih sredstvih lahko sočasno zdravljenje z zdravili, ki imajo antimuskarinske lastnosti, na primer z oksibutininom, s tolterodinom in flavoksatom, povzroči izrazitejše terapevtske in neželene učinke.

as antimuscarinic bronchodilator medicines may have an effect on the heart and blood vessels, the company will continue to closely monitor the medicine’s cardiovascular effects and will carry out a further study in patients to identify any potential risks.
antimuskarinska bronhodilatacijska zdravila lahko vplivajo na srce in ožilje, zato bo družba pozorno spremljala učinke zdravila na srce in ožilje ter izvedla dodatno študijo pri bolnikih za ugotovitev morebitnih tveganj.

pharmacological interactions caution should be exercised in coadministration of fesoterodine with other antimuscarinic agents and medicinal products with anticholinergic properties (e. g. amantadine, tri-cyclic antidepressants, certain neuroleptics) as this may lead to more pronounced therapeutic- and side-effects (e. g. constipation, dry mouth, drowsiness, urinary retention).
farmakološke interakcije pri sočasni uporabi fesoterodina in drugih zdravil z antimuskarinskimi in antiholinergičnimi lastnostmi (npr. amantadin, triciklični antidepresivi, nekateri nevroleptiki) je potrebna previdnost, ker lahko povzroči bolj izražene terapevtske učinke in neželene učinke (npr. zaprtje, suha usta, dremavost, retencijo urina).